Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology
Clinical Trials: Glioblastoma multiforme
A listing of clinical trials currently looking for volunteers to enroll in Glioblastoma multiforme studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Arizona
Tucson : Arizona Cancer Center
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
California
Duarte : City of Hope Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
La Jolla : UC San Diego Moores Cancer Center
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
La Jolla : University of California San Diego Moores Cancer Center
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
La Jolla : UCSD Moores Cancer Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Los Angeles : Cedars-Sinai Medical Center
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
View More »
Los Angeles : University of California, Los Angeles
AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
Los Angeles : University of Southern California
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Los Angeles : UCLA Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Los Angeles : Cedars-Sinai Medical Center-Samuel Oschin Comprehensive Cancer Institute Updated
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
Los Angeles : UCLA Neuro-Oncology Program Updated
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
Newport Beach : Hoag Memorial Hospital Presbyterian Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Newport Beach : Hoag Cancer Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Sacramento : Sutter Institute for Medical Research Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
San Francisco : University of California at San Francisco Updated
Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma
San Francisco : University of California at San Francisco Updated
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
South Pasadena : South Pasadena Cancer Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Colorado
Aurora : University of Colorado Denver, University of Colorado Cancer Center
Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme
Florida
Jacksonville : Call for Information (Investigational Site 0002)
Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)
Miami Beach : Mount Sinai CCOP Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Orlando : MD Anderson Cancer Center Orlando
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Tampa : H. Lee Moffitt Cancer Center and Research Institute
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
Tampa : H. Lee Moffitt Cancer Center & Research Institute
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
View More »
Tampa : Moffitt Cancer Center & Research Institute Updated
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
Illinois
Chicago : Northwestern Memorial Hospital
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
Chicago : Rush University Medical Center
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
Chicago : Northwestern University Feinberg School of Medicine
AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
Chicago : University of Illinois at Chicago
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Chicago : Rush University Medical Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
View More »
Chicago : University of Illinois Medical Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Chicago : Northwestern University - Robert H Lurie Comprehensive Cancer Center
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Peoria : Illinois Cancer Care Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Indiana
Indianapolis : IU Simon Cancer Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Kentucky
Lexington : University of Kentucky - Markey Cancer Center
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Louisville : Jewish Hospital Medical Center
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
Maine
Scarborough : Maine Medical Center
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Massachusetts
Boston : Massachusetts General Hospital
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
Boston : Tufts Medical Center
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Boston : Dana-Farber Cancer Institute
PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma
Boston : Massachusetts General Hospital
PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma
Boston : Tufts Medical Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
View More »
Burlington : Lahey Clinic Medical Center
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Michigan
Ann Arbor : University of Michigan, Department of Neurosurgery Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Detroit : Henry Ford Health Systems
AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
Detroit : Henry Ford Hospital
PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma
Detroit : Henry Ford Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Detroit : Henry Ford Hospital
Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
Minnesota
Minneapolis : Virginia Piper Cancer Institute Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Rochester : Call for Information (Investigational Site 0005)
Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)
Missouri
Kansas City : St. Luke's Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Kansas City : Saint Luke's Hospital
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
Saint Louis : Washington University
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
St. Louis : Washington University School of Medicine Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
New Hampshire
Lebanon : Dartmouth Hithcock Medcial Center
Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM)
New Jersey
Edison : New Jersey Neuroscience Institute
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
Edison : New Jersey Neuroscience Center - JFK Medical Center
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Edison : JFK Medical Center
Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
Hackensack : John Theurer Cancer Center at Hackensack University Medical Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Hackensack : John Theurer Cancer Center at Hackensack University Updated
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
View More »
New Brunswick : Cancer Institute of New Jersey
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
Summit : Overlook Hospital
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
Summit : Overlook Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
New York
Manhasset : Biomedical Research Alliance of New York
Glioblastoma (Brain Tumor) and Unmethylated MGMT Gene - Adults
Manhasset : Biomedical Research Alliance of New York
Glioblastoma Multiforme (Brain Cancer) - Adults
View More »
Amherst : Dent Neurologic Institute
Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)
Commack, Great Neck : Long Island Brain Tumor Centre at Neurological Surgery P.C. Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Great Neck : The Long Island Brain Tumor Center at Neurological Surgery, PC
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
Huntington : Huntington Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Lake Success : North Shore - Long Island Jewish Hospital/Monter Cancer Center
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Manhasset : North Shore University Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Mineola : Winthrop University Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
New York : NYU Clinical Cancer Center
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
New York : Investigational Site Number 165464
A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas
New York : Weill Cornell Medical College
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
New York : The New York Hospital/ Weill Medical College
Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma
New York : New York University Clinical Cancer Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
New York : NYU Cancer Institute Updated
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
Oceanside : South Nassau Community Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Rochester : University of Rochester Medical Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Rockville Centre : Mercy Medical Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
White Plains : Brain and Spine Surgeons of New York and Northern Westchester Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
North Carolina
Chapel Hill : University of North Carolina Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Durham : The Preston Robert Tisch Brain Tumor Center
AMG 102 and Avastin for Recurrent Malignant Glioma
Durham : Duke University Medical Center
Amgen 386 for Recurrent Glioblastoma
Durham : Duke University Medical Center
AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
Durham : The Preston Robert Tisch Brain Tumor Center
Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)
View More »
Winston Salem : Wake Forest University
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
Winston-Salem : Derrick L Davis Forsyth Regional Cancer Center
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Ohio
Cincinnati : University of Cincinnati
Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients
Cincinnati : UC Cancer Institute Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Cleveland : Case Comprehensive Cancer Center
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
Cleveland : Cleveland Clinic Rose Ella Burkhardt Brain Tumor and Neuro Oncology Center
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
Cleveland : Cleveland Clinic Taussig Cancer Center
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
View More »
Cleveland : Cleveland Clinic
Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)
Cleveland : Cleveland Clinic Foundation Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Cleveland : University Hospitals of Cleveland Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Columbus : Ohio State University
Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
Columbus : The Ohio State University - James Comprehensive Cancer Center
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Oregon
Portland : Oregon Health and Sciences University
Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma Multiforme or Other Recurrent Malignant Gliomas
Portland : Providence Cancer Center
Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma Multiforme or Other Recurrent Malignant Gliomas
Pennsylvania
Danville : Geisinger Health System
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Hershey : Penn State Hershey Medical Center
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
Philadelphia : Thomas Jefferson University
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
Philadelphia : University of Pennsylvania
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
Pittsburgh : University of Pittsburgh Medical Center
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Rhode Island
Providence : Rhode Island Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
South Carolina
Tennessee
Nashville : Tennessee Oncology
Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
Nashville : Sarah Cannon Research Institute
Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma
Nashville : St. Thomas Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Nashville : Vanderbilt Ingram Cancer Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Nashville : Sarah Cannon Research Institute (SCRI) Drug Development Unit Updated
Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma
View More »
Nashville : Sarah Cannon Research Institute (SCRI) Updated
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
Texas
Dallas : Sammons Cancer Center (Baylor)
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
Dallas : Baylor Research Institute
AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
Dallas : Baylor
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Dallas : Baylor Research Institute Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Dallas : Mary Crowley Cancer Research Centers Updated
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
View More »
Dallas : Baylor University Medical Center
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
Houston : University of Texas Health Science Center at Houston
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
Houston : The University of Texas Health Science Center at Houston
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Houston : Methodist Hospital
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Houston : Methodist Neurological Institute
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Houston : UT MD Anderson Cancer Center
Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)
Houston : Call for Information (Investigational Site 0001)
Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)
Houston : UT MD Anderson Cancer Center
Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)
Virginia
Charlottesville : University of Virginia Health System
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
Washington
Seattle : Swedish Neuroscience Institute
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Seattle : Swedish Hospital Neuroscience Research Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Wisconsin
Green Bay : Aurora BayCare Medical Center
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
Austria
Feldkirch : Landeskrankenhaus Feldkirch
Dendritic Cell Cancer Vaccine for High-grade Glioma
Graz : University Hospital Graz
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Innsbruck : Medical University Innsbruck
Dendritic Cell Cancer Vaccine for High-grade Glioma
Linz : Landesnervenklinik Wagner-Jauregg
Dendritic Cell Cancer Vaccine for High-grade Glioma
Vienna : Kaiser Franz-Josef Spital
Dendritic Cell Cancer Vaccine for High-grade Glioma
View More »
Vienna : Medical University Vienna
Dendritic Cell Cancer Vaccine for High-grade Glioma
Vienna : Donauspital, SMZ-Ost
Dendritic Cell Cancer Vaccine for High-grade Glioma
Czech Republic
Prague : Jan Sroubek
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Denmark
Copenhagen : Updated
A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma
France
Lyon : Hospital of Neurology Lyon - University Claude Bernard
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Marseille : Updated
A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma
Paris : Group Hospitals Pitie-Salpetriere
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Toulouse : Centre Hospitalo-Universitaire de Toulouse Purpan
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Toulouse Cedex : Institut Claudius Régaud Updated
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
View More »
Villejuif Cedex : Institut Gustave Roussy, Dept. of Medicine Updated
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
Germany
Berlin : Updated
A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
Bochum : Updated
A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
Bonn : Updated
A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
Chemnitz : Updated
A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
Dresden : Updated
A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
View More »
Düsseldorf : Updated
A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
Erfurt : Updated
A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
Frankfurt : Updated
A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
Freiburg : Updated
A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
Göttingen : Updated
A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
Hamburg : University Medical Center Hamburg-Eppendorf
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Heidelberg : Medical University Heidelberg
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Heidelberg : Department of Neurosurgery, University Hospital Heidelberg
Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.
Heidelberg : University of Heidelberg
Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)
Kiel : Updated
A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
Kiel : University Hospital of Schleswig-Holstein
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Köln : Updated
A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
Leipzig : Updated
A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
Mannheim : Updated
A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
München : Updated
A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
Regensburg : Updated
A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
Tübingen : Updated
A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
Israel
Tel Aviv : Tel Aviv Sourasky Medical Center
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Italy
Bologna : Updated
A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma
Genova : Updated
A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma
Milan : Foundation Hospital Greater Policlinico
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Milan : C. Besta Neurological Institute
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Milano : Updated
A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma
View More »
Padova : Updated
A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma
Roma : Updated
A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma
Rome : Istituti Fisioterapici Ospitalieri - Istituto Nazionale dei Tumori Regina Elena
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
San Giovanni Rotondo : Updated
A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma
Terni : Updated
A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma
Spain
Salamanca : Hospital Universitario de Salamanca Updated
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
Seville : Servicio de Oncologia Medica Sala de Investigación Updated
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
Switzerland
Lausanne : Centre Hospitalier Universitaire Vaudois (CHUV)
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Zürich : Updated
A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma
United Kingdom
Manchester : Updated
A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma
United States
Washington : Georgetown University Medical Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer